Although the use of stimulants continues to increase in all age groups in the United States,¹ an important debate has emerged in the last 2 years about how effective stimulants are for treating attention-deficit/hyperactivity disorder (ADHD). For some investigators, the main message in the literature is clear: the quality of evidence from randomized clinical trials on the efficacy of stimulants is poor.² For others, the problem is in the meta-analysis from which these conclusions were taken.³

中文翻译：

---

兴奋剂的疗效超出注意力缺陷/多动障碍的核心症状的治疗

虽然使用兴奋剂继续在美国所有年龄组增加，^1周一个重要的争论已经出现在过去的2年关于兴奋剂如何有效用于治疗注意力缺失/多动症（ADHD）。对于一些研究者而言，文献中的主要信息很明确：关于兴奋剂功效的随机临床试验证据质量很差。²对于其他人，问题出在得出这些结论的荟萃分析中。³